State T21, Restrictions on Flavored E-Cigarette Products, and Non-Medical Cannabis Sales Legalization in Relation to Young Adult Reports of Vape Shop Age Verification and Product Offerings: A Multilevel Analysis
-
Published:2022-11-16
Issue:22
Volume:19
Page:15079
-
ISSN:1660-4601
-
Container-title:International Journal of Environmental Research and Public Health
-
language:en
-
Short-container-title:IJERPH
Author:
Duan ZongshuanORCID, Wang Yan, Romm Katelyn F.ORCID, Henriksen Lisa, Schleicher Nina C., Berg Carla J.ORCID
Abstract
Vape shop practices related to age verification and product offerings (e.g., other tobacco, cannabis), which may affect young-adult tobacco/substance use, are likely impacted by state-level policies (i.e., Tobacco 21 [T21], flavored e-cigarette restrictions, non-medical cannabis legalization). Using data from young adults (18–34 years) in 6 US states representing variability in whether/when they implemented the aforementioned policies, this study focused on past 6-month e-cigarette users who visited vape shops (Wave 1 [W1]: September–December 2018, n = 1127; W2: September–December 2019, n = 702; W3: September–December 2020, n = 549). Multilevel modeling examined T21 in relation to participants’ reports of age verification at last vape shop visit (among those < 27), and flavor restrictions and cannabis legalization in relation to noticing other tobacco or cannabis products at last visit. At W1–W3, 69.7%, 78.7%, and 75.8% of participants < 27 reported age verification, and participants increasingly noticed other tobacco (W2: 36.9%; W3: 48.6%) and cannabis products (W1: 25.8%; W2: 41.3%; W3: 58.3%). State T21 was unrelated to age verification (aOR = 1.19, 95%CI = 0.80–1.79); flavored e-cigarette restrictions correlated with noticing other tobacco products (aOR = 1.96, 95%CI = 1.10–3.51); flavored e-cigarette restrictions (aOR = 2.26, 95%CI = 1.57–3.24) and cannabis legalization (aOR = 2.84, 95%CI = 1.78–4.51) correlated with noticing cannabis products. Regulatory efforts must be informed by ongoing surveillance of such policies and their impact.
Funder
National Cancer Institute Fogarty International Center National Institute of Environmental Health Sciences National Institute on Drug Abuse
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference54 articles.
1. Boosting the tobacco control vaccine: Recognizing the role of the retail environment in addressing tobacco use and disparities;Tob. Control,2021 2. Tobacco companies introduce ‘tobacco-free’nicotine pouches;Tob. Control,2020 3. Duan, Z., Henriksen, L., Vallone, D., Rath, J.M., Evans, W.D., Romm, K.F., Wysota, C., and Berg, C.J. (2022). Nicotine pouch marketing strategies in the USA: An analysis of Zyn, On! and Velo. Tob. Control,
ahead of print
. 4. Berg, C.J., Abroms, L.C., Levine, H., Romm, K.F., Khayat, A., Wysota, C.N., Duan, Z., and Bar-Zeev, Y. (2021). IQOS Marketing in the US: The need to study the impact of FDA Modified exposure authorization, marketing distribution channels, and potential targeting of consumers. Int. J. Environ. Res. Public Health, 18. 5. Henderson, K.C., Van Do, V., Wang, Y., Duan, Z., Popova, L., Spears, C.A., Weaver, S.R., Ashley, D.L., Barker, D.C., and Huang, J. (2022). Brief report on IQOS point-of-sale marketing, promotion and pricing in IQOS retail partner stores in Atlanta, Georgia, USA. Tob. Control,
ahead of print
.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|